Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period

BACKGROUND: Isocitrate dehydrogenase (IDH) mutated diffuse lower-grade gliomas (dLGG) are infiltrating brain tumors and increasing evidence is in favor of early multimodal treatment. In a Scandinavian population-based setting, we wanted to study treatment patterns over the last 15 years, focusing on...

Descripción completa

Detalles Bibliográficos
Autores principales: Svenjeby, Caroline, Carstam, Louise, Werlenius, Katja, Bontell, Thomas Olsson, Rydén, Isabelle, Jacobsson, Julia, Dénes, Anna, Jakola, Asgeir S., Corell, Alba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758083/
https://www.ncbi.nlm.nih.gov/pubmed/36434487
http://dx.doi.org/10.1007/s11060-022-04136-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758083/
https://www.ncbi.nlm.nih.gov/pubmed/36434487
http://dx.doi.org/10.1007/s11060-022-04136-y

Ejemplares similares